Table S1 - Increased Arterial Diameters in the Posterior Cerebral Circulation in Men with Fabry Disease

Characteristics of study population including treatment regimen with enzyme replacement therapy. 1 Alpha-galactosidase alpha 0,2 mg/kg every second week 2 Alpha-galactosidase beta 1 mg/kg every second week 3 Alpha-galactosidase beta 1 mg/kg every second week, but with reduced dose during the period of product shortage 4 Alpha-galactosidase beta 1 mg/kg every second week, switched to alpha-galactosidase alpha during the period of product shortage Abbreviations: ERT: enzyme replacement therapy; F: female; M: male; cMRI: cranial magnetic resonance imaging.
(DOC)